Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Retained Earnings of -$310.5 million for Q1 2026, down 38.49% on a YoY basis from -$504.8 million in Q1 2025, and down 6.28% sequentially from -$292.2 million in Q4 2025.
Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Retained Earnings data on file, last reported at -$310.5 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 38.49% year-over-year to -$310.5 million; the trailing twelve-month figure through Mar 2026 stood at -$310.5 million (down 38.49% YoY), and the FY2025 full-year result was -$292.2 million, down 37.97% from the prior year.
- Retained Earnings slipped to -$310.5 million in Q1 2026, from -$292.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $36.2 million in Q4 2023 to a low of -$310.5 million in Q1 2026.
- A 4-year average of -$211.2 million and a median of -$230.5 million in 2025 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings sank 684.45% in 2024 and fell 26.9% in 2025, its largest moves.
- Tracing CAMP's Retained Earnings over 4 years: stood at $36.2 million in 2023, then slumped by 684.45% to -$211.8 million in 2024, then tumbled by 37.97% to -$292.2 million in 2025, then decreased by 6.28% to -$310.5 million in 2026.
- Business Quant data shows CAMP's Retained Earnings at -$310.5 million in Q1 2026, -$292.2 million in Q4 2025, and -$251.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -310.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -310.50 Mn |
| Dec 31, 2025 | -292.16 Mn |
| Sep 30, 2025 | -251.90 Mn |
| Jun 30, 2025 | -236.77 Mn |
| Mar 31, 2025 | -224.20 Mn |
| Dec 31, 2024 | -211.75 Mn |
| Sep 30, 2024 | -198.50 Mn |
| Dec 31, 2023 | 36.23 Mn |